Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Allogeneic Bone Marrow Derived Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients

NCT02387151 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT02387151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02387151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Allogeneic Bone Marrow Derived Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
Lead sponsor
Leiden University Medical Center
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2015
Completion date
November 30, 2018
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft loss, rejection